Nanobac Pharmaceuticals's total assets for Q were $7.22M, a decrease of -1.67% from the previous quarter. NNBP total liabilities were $9.58M for the fiscal quarter, a 0.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.